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Hypothesis 
Analysis of /3-tubulin sequences reveals highly conserved, coordinated 
amino acid substitutions 
Evidence that these ‘hot spots’ are directly involved in the conformational change 
required for dynamic instability 
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Vertebrate /-tubulins have been classified into six classes on the basis of their C-terminal sequences [(1987) J. Cell Biol. 105, 170771720]. In particu- 
lar, the sequences starting at residue 430 differ between isotypes of the same animal but are conserved between species. We extend this analysis 
and show that there are three ‘hot spots’, at residues 35, 55-57 and 124 which exhibit intra-species heterogeneity but inter-species conservation. 
There is a remarkable correlation between the identity of these residues and the C-terminal sequences, and suggests that the vertebrate /I-tubulins 
fall into three broad types. This correlation extends to those non-vertebrate organisms which have the Type 1 C-terminal sequence. We propose 
that these three ‘hot spots’ and the C-terminal peptide interact in the tertiary structure. We have also noted that the C-terminal peptide almost 
always contains a single phenylalanine or tyrosine residue, and that there is a strong correlation between this residue and the amino acids at positions 
217:‘218, in both the vertebrate and non-vertebrate sequences. We propose that the C-terminal aromatic amino acid interacts with residues 217/218 
in the tertiary structure. Analysis of conditions which stabilise microtubules and/or lower the steady state critical concentration strongly suggests 
that these two sets of coordinated amino acid substitutions are directly involved in effecting the conformational change associated with GTP hydrol- 
ysis which results in dynamic instability. We propose that there is an interaction between the highly acidic sequence between residue 430 and the 
aromatic amino acid (termed peptide A) and conserved basic amino acids located close to the ‘hot spots’. We suggest that this interaction is altered 
in response to the assembly-dependent GTP hydrolysis, with the consequential increase in the subunit dissociation rate constant. 
p-Tubulin; Coordinated substitution; Dynamic instability 
1. CLASSIFICATION OF VERTEBRATE 
,&TUBULINS 
The cy- and ,B-tubulins are both highly conserved, 
with the most extreme diversity being confined to the 
C-terminal sequences [ 11. For example, only 15.6% of 
residues l-430 are different between any of the seven 
chick ,B-tubulins, and almost 40% of these are unique 
to the p-6 isotype, while the C-terminal peptides (from 
residue 431) are both variable in length and amino acid 
sequence. 
This heterogeneity is unusual since P-tubulin 
isoforms with virtually identical C-terminus sequences 
are found in different organisms. This led Cleveland 
and co-workers to divide all vertebrate P-tubulins into 
six classes based on their C-terminal sequences (suc- 
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cessively developed in [2-51). The limited evidence 
available indicated that the expression of these dif- 
ferent isotypes in different tissues is also conserved. All 
cells of higher organisms yet examined contain a mix- 
ture of different isotypes [5-71. 
We have applied this approach of identifying intra- 
species heterogeneity but inter-species homology to the 
highly conserved portion of the vertebrate &tubulin se- 
quences (l-430), and have also identified a conserved 
feature within the extremely heterogeneous C-terminal 
peptide (431 -). 
2. IDENTIFICATION OF COORDINATED 
CHANGES 
We have noticed three ‘hot spots’ which, like the C- 
terminal peptide, vary between different isotypes from 
the same vertebrate yet are conserved between species 
(see Table I). These ‘hot spots’ are located at residues 
35, 55-57 and 124, positions previously recognised as 
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Table I 
October 1990 
Compilation of known vertebrate and non-vertebrateB-tubulin sequences around the ‘hot spots’ at residues 35. 55-57, and 124, the C-terminal 
peptide, and the sequences surrounding residues 2 17/21X 
All sequences, apart from that of Cuenorhabdifis tub I, Epichloe and Limneu, have been taken from published reports. The analysis assumes 
that there have been no sequencing errors. The vertebrate sequences are assigned to the proposed Types and to the Classes as defined by Cleveland. 
The insertion in the ~~o~o~hj~~ B-3 sequence at residue 54 is shown. Eash C-terminal peptide starts at residue 430, the last of the conserved 
sequence, and are aligned relative, when present, to the aromatic residue. The identity of this aromatic residue (F or Y) is shown: X indicates 
those C-terminal sequences lacking this feature. The residues surrounding positions 2171218 are sub-divided according to the identity of this 
aromatic residue. Residues at 217/218 which differ from the conserved Thr2”/Thr2’s m the first (phenylalanine) block are shown in italics. The 
Trypanosoma cruzei sequence is labelled * as the C-terminal sequence is unknown. The ends of known sequences are marked by square brackets 
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being highly variable [2]. There is a remarkable correla- 
tion between the identity of these residues and the C- 
terminal sequence (Table I). The substitutions at these 
‘hot spots’ represent a significant fraction of all those 
within the first 430 residues: for example, they include 
a quarter of the residue differences between chick p-7 
and chick ,&l/2. 
These ‘hot spots’ have three striking features. First, 
a change at one site is always accompanied by the ap- 
propriate changes at the other two sites, apart from cer- 
tain minor exceptions which will be considered later. 
Secondly, the same substitutions are found in all p- 
tubulins of the same class as defined by their C- 
terminal peptides. Thirdly, the converse does not app- 
ly: Class I and IV ,&tubulins have distinct but related 
C-terminal peptides, but have identical residues at the 
‘hot spots’. Vertebrate ,/3-tubulins can therefore be 
divided into three types; Type 1 includes Classes 1 and 
IV, Type 2 is equivalent to Class II, while Type 3 is 
more heterogeneous and includes Classes III, V and VI. 
This heterogeneity of Type 3 is illustrative of the 
minor exceptions. Inspection of the ‘hot spot’ residues 
clearly shows that Classes III, V and VI are closely 
related to each other, with minor variants, e.g. CYS’*~ 
is replaced by a serine in the mouse ,&l isotype. The se- 
cond group of exceptions are point substitutions in the 
flanking sequence, such as the replacement of AlaSS by 
threonine in the Class II chick ,&2 isotype, and LYS~~ by 
asparagine in mouse ,&4. Finally, the pig sequences, 
determined by peptide analysis, have been allocated to 
Classes II and III on the basis of their homologies, their 
neuronal origin, and the evidence that the tubulin con- 
tains a mixture of isotypes [8,9]. 
Several of the non-vertebrate sequences share a very 
high sequence homology with the vertebrate Type 1 at 
all three ‘hot spots’ and their flanking regions (Table I), 
and most of these (Chlamydomonas fll and 2, 
Tetrahymena ,YTTl and 2, Trypanosoma brucei, and 
I/ofvox) have a C-terminal sequence which is either 
identical or closely resembles that of the Type 1 Class 
IV (Table I). A similar homology with respect to the 
‘hot spots’ and residues 431-436 applies to Paracen- 
trotus, Euplotes, Toxoplasma ,&tubulins and to one 
Plasmodium isotype. This does not apply to any of the 
other C-terminal sequences, with the exception of 
Lytechinus and Strongylocentrotus for which the ‘hot 
spot’ sequences are unknown. Stylonychia p-1 and p-2 
have the vertebrate Type 1 ‘hot spots’ but a significant- 
ly different C-terminal peptide, while Polytomella ,B- 
tubulins have the vertebrate Type 1 C-terminal se- 
quences but different ‘hot spots’. 
Almost all the non-vertebrate sequences closely 
resemble the vertebrate Type 1 around residue 124, 
while greater heterogeneity is apparent around the 
other two ‘hot spots’. This may relate to a common 
functional property of most ,&tubulins. 
The flanking regions of the three vertebrate and non- 
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vertebratep-tubulin ‘hot spots’ contain three conserved 
basic residues: Arg5s/Lys5X/Asn’8, Arg”’ (except for 
Trypanosoma brucei), and Arg’22/Lys’2’/Asn’2’. His” 
is also conserved in the vertebrate Types 1 and 2 (but 
not Type 3), while many non-vertebrate sequences have 
a basic residue at this position (Table I). 
Almost all of the C-terminal sequences contain a 
single tyrosine or phenylalanine residue. This partially 
conserved residue splits the C-terminal sequence into 
what we shall define as peptide A, between the conserv- 
ed Ala430 and the aromatic site, and peptide B which ex- 
tends from this site to the C-terminus. The sequence of 
peptide A is virtually identical for all vertebrate Type 
1 and non-vertebrate P-tubulins having the Type 1 ‘hot 
spots’, while the sequence of peptide B is more variable 
(Table I). 
The conserved aromatic residue is tyrosine in chick 
p-4, p-6 and human p-4, but is phenylalanine in all 
other vertebrate isotypes. Examination reveals that 
these three exceptions contain a single unique change: 
residues 217/218. The amino acids at residues 2171218 
correlate with the identity of the conserved aromatic 
residue for almost every known fi-tubulin (Table I): 
with Thr2”-Thr218 when tyrosine is conserved but other 
residues for the phenylalanine C-terminal peptides. 
There are just five exceptions: Drosophilafl-3, which is 
unusual in that it contains the sole known insertion 
[lo], Saccharomyces cerevisiae with its highly divergent 
C-terminal peptide (Table I), and Giardia, while both 
Zea and Euplotes have a phenylalanine in the C- 
terminal peptide but the Thr”‘-Thr”* characteristic of 
the tyrosine C-terminal peptide. Residues 217/218 are 
not noticeably dissimilar in the eight C-terminal se- 
quences lacking a conserved aromatic residue. 
We have therefore identified two sets of coordinated 
yet independent changes: a remarkable correlation bet- 
ween the ‘hot spots’ at residues 35, 55-57 and 124 and 
peptide A of the C-terminal sequence of all vertebrate 
and many non-vertebrate P-tubulins, and a strong cor- 
relation between the identity of aromatic residue of the 
C-terminal sequence and the identity of residues 
217/218. 
3. POSSIBLE ORIGINS OF THE COORDINATED 
CHANGES 
One possibility is that the tubulin sequence is so 
highly constrained by the required tertiary structure 
that a substitution at one position requires the other 
changes for the protein to preserve its conformation. 
There is considerable evidence against this possibility 
for the correlation between the C-terminal sequence 
and the three ‘hot spots’. First, the different fl-tubulins 
contain many other amino acid substitutions, although 
there are no other equivalent ‘hot spots’ in either thep- 
or the a-subunit, while there are an increasing number 
of functional ,0-tubulin mutants (for examples, see 
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[ll-131). Secondly, the products of yeast-chick 
chime& genes are assembled in vivo following 
transfection [14,15], even though S. cerevisiue tubulin 
and chick p-1 sequences only share ==70% identity [16]. 
Furthermore, the Drosophila ,L?-3 sequence contains an 
insertion of six residues at position 54, i.e., almost im- 
mediately adjacent o one of the ‘hot spots’, which does 
not appear to adversely affect its function [ IO]. Finally, 
many non-vertebrate ,8-tubulins show considerable 
heterogeneity at these three positions, while the 
vertebrate ,&ubulins can accommodate amino acid 
changes at adjacent positions (Table I). 
The alternative possibility is that the coordinated 
substitutions are functionally significant. This would 
imply that residues at the three ‘hot spots’ and the C- 
terminal peptide interact with each other in the tertiary 
structure, i.e. these four parts of the primary sequence 
are brought into close proximity by the folding of the 
peptide chain to form a ‘complex’. The term ‘complex’, 
rather than ‘pocket’, has been used in order to avoid 
implying any specific geometry. The ‘hot spots’ and the 
C-terminal peptide would represent highly conserved 
sequences rather than permitted heterogeneity 1171. 
Similarly, the correlation between the C-terminal 
aromatic residue and positions 2171218 implies that 
they interact in the tertiary structure. 
Consideration of residues 35, 55-57, 124 and the C- 
terminal peptide strongly suggests that the ‘complex’ is 
on or close to the exposed surface of the assembled 
microtubule. First, monoclon~ antibodies against 
epitopes at residues 416-430 and 422-434 label 
assembled microtubules [l&-20]. The N-terminal 
residues of peptide A therefore lie on the outer subunit 
surface of the assembled microtubule. Similarly, pep- 
tide B is also exposed as isotype-specific polyclonal an- 
tibodies raised against C-terminal peptides label 
assembled microtubules [4,5], while a second MAP- 
binding consensus sequence (EGEE, PllIA 
characteristic of cu-tubulin, is located at residues 
444-447 of certain of the Type 2 Class II isotypes 
(Table I). 
Secondly, the predicted hydrophilicity, as reported 
by De la Vina et al. [19], and independentIy confirmed, 
shows that residue 124 lies in one of the most 
hydrophilic regions. It is therefore unlikely to be buried 
in either the hydrophobic core or at a subunits/subunit 
interface, and is probably on the exposed surface of the 
assembled microtubule. Residues 55-57, which are also 
moderately hydrophilic, lie immediately adjacent to the 
inserted six additional amino acids of the Drosophila 
p-3 sequence [lo]. This insertion probably forms a loop 
which extends from the assembled microtubule, thus 
placing residues 55-57 at or close to the exposed 
subunit surface. Finally, the sequence at residues 33-38 
of Eugfena &tubulin is totally different from those of 
all other ,8-tubulins (see Table I), despite a high 
homology elsewhere, and involves the deletion of a 
single residue. It is extremely unlikely that this highly 
altered sequence is buried within the tertiary structure 
since other changes would be predicted, and therefore 
it may lie at or close to the subunit surface. 
There is no equivalent corroborative evidence show- 
ing that the conserved aromatic amino acid and 
residues 217/218 are spatially related. Significantly, no 
antibodies or other proteins have been shown to bind 
at or close to the aromatic residue, while the predicted 
hydrophilicity of residues 217/218 is not significantly 
high. 
4. FUNCTIONAL ROLE 
SUBSTITUTlONS 
The C-terminal peptide 
OF TI-IE COORDINATED 
has been implicated in the 
binding of Microtubule Associated Proteins such as the 
neuronal MAP2 and tau 1221. The function of the pro- 
posed ‘complex’ is unlikely to relate specifically to 
either of these proteins since both are neuron-specific, 
while the three types are each found in both neuronal 
and non-neuronal tissues. The ‘complex’ could be the 
binding site for more ubiquitous proteins, e.g. 
microtubule motors such as kinesin, dynein and 
dynamin; other MAPS, such as MAPIA and the 
205-210 kDa family; bundling proteins, such as 
glyceraldehyde-3-phosphate dehydrogenase [23]; or 
proteins which specifically interact with the P-subunit 
such as the protein kinase which phosphorylates the 
Type 3 Class III fi-tubulin 1241 and tubulinyl tyrosine 
kinase [25]. The most persuasive argument against this 
possibility is that CVI cells only contain Type 1, 
Classes I and IV [5], yet such cells are likely to have 
typical requirements for the various associated pro- 
teins. Furthermore, the function of this ‘complex’ is 
unlikely to be simply an on/off switch, since this could 
be effected by just two classes. Indeed, the vertebrate 
Class I and Class II P-tubulins have identical ‘hot spot’ 
residues but have different C-terminal peptides, which 
suggests that their exact sequences are functionally im- 
portant in specifying the properties of the ‘complex’. 
An alternative possibility is that the function of the 
coordinated changes relates to an intrinsic property of 
the tubulin subunit. Microtubules exhibit dynamic in- 
stability [26]. This behaviour reflects the existence, at 
steady state, of two slowly interconverting sub- 
populations of microtubules, one which is elongating 
while the other is rapidly shortening [27]. The two sub- 
populations have different critical concentrations (C, 
or the ratio of the dissociation to association rate cons- 
tant), such that one sub-population, with the lower C,, 
continues to elongate at the expense of the other. 
The transition between the elongating and shortening 
phases is generally believed to be a direct consequence 
of the assembly-dependent hydrolysis of GTP bound to 
the P-subunit [28], such that only the former terminate 
in a ‘GTP-cap’. GTP hydrolysis greatly enhances the 
5 
Volume 271, number 1,2 FEBS LETTERS October 1990 
dissociation rate constant (i.e. k!!sp < h!??‘), and this 
underlies the difference in the C,, of capped and uncap- 
ped microtubules. The change in the dissociation rate 
constant indicates that the tubulin dimer alters its con- 
formation. As GTP hydrolysis occurs at the ex- 
changeable site on the &subunit, the primary 
conformational change is likely to occur in this subunit. 
Tubulin can therefore exist in a minimum of two 
conformational states, with the transition from one 
state to the other influencing the lability of the assembl- 
ed microtubule. One intriguing possibility is that the 
various isotypes respond differently to this assembly- 
dependent GTP hydrolysis, and that microtubules 
assembled from specific isotypes exhibit dynamic in- 
stability to different extents, while those consisting of 
a mixture of isotypes have intermediate properties. 
Unfortunately, it has not yet been possible to prepare 
significant amounts of tubulin containing single N- and 
P-isotypes. However, the successive use of isotype- 
specific antibody affinity chromatography has permit- 
ted the purification of pig cy- and Pz- (Type 3, Class III) 
tubulin [29]. Microtubules assembled from this protein 
are reportedly more stable than those from the unfrac- 
tionated tubulin [30]. The enhanced stability may be a 
direct consequence of the ,&2-isotype or microtubules 
assembled from a mixture of isotypes may be intrin- 
sically more labile. 
The erythrocyte tubulin provides the clearest 
evidence that the dynamic properties relate to the 
isotype composition. Erythrocyte tubulin consists of a 
mixture of Types 1 and 3 [4], while brain tubulin con- 
tains all three types [29]. Assembly studies have shown 
that the erythrocyte tubulin differs from the brain pro- 
tein in having a lower steady state Co [3 1,321. This C, 
reflects the number average of the relative dissocia- 
tion/association rate constants of the elongating and 
shortening microtubule sub-populations, and therefore 
the lower value may be due, in part, to an altered 
response to the assembly-dependent GTP hydrolysis. 
We also note that four of the experimental methods 
for either lowering the steady state C,, or enhancing the 
extent of assembly relate to either the C-terminal pep- 
tide or to a probable interaction between this highly 
anionic peptide and a cationic site. These are: (i) the ad- 
dition of MAPS such as MAP2 and tau, which bind to 
consensus sites at either end of the C-terminal peptide. 
Such MAPS inhibit dynamic instability [33,34] and 
lower the steady state C,, (for example, [35]) to ex- 
perimental values which are similar to those determined 
for the elongating sub-population of pure tubulin 
microtubules (for example, see [26,27]). Significantly, 
tau lowers the steady state C, but does not affect the in- 
itial elongation rate [36]. (ii) The truncation of both cy- 
and ,&tubulin by 7-15 residues by subtilisin digestion 
137-391. (iii) The addition of polycations, with the for- 
mation of double-walled microtubules and other 
polymorphs, which probably bind to the highly acidic 
6 
C-terminal peptide [40,41]. (iv) The use of assembly 
buffers containing very high (= 1 M) sodium glutamate 
which may saturate sites normally occupied by the C- 
terminal glutamic acid residues [42]. 
Peptide A, rather than peptide B, is involved in 
lowering of the steady state C,. Subtilisin digestion 
results in the complete removal of peptide B and an 
unknown amount of peptide A, yet truncation of pep- 
tide B to = residue 438 by carboxypeptidase Y has no 
effect on the steady state C, [43]. Peptide A is also 
directly involved in the binding to the repeated consen- 
sus sequences of MAP2 and tau [44-461, both of which 
lower the steady state C,, since these proteins bind to 
a synthetic peptide of residues 422-434 [47]. Other 
studies, using [‘251]MAP2 and [‘251]tau, have detected 
strong binding to synthetic peptides of residues 
426-440, 426-445 and 434-445 but not to the peptides 
416-425 or 416-43 1 [48]. At least one MAP-binding 
site therefore appears to be specified by residues close 
to position 434, i.e. towards the N-terminus of peptide 
A, and directly implicates peptide A in effecting the 
conformational change associated with dynamic in- 
stability. 
This conformational change presumably involves 
relative movement between the three domains apparent 
from low angle X-ray diffraction [49]. One interesting, 
but speculative, possibility is that this change involves 
an association of peptide A with two of these domains. 
A synthesis of the available sequence information sug- 
gests that the N-terminus of peptide A interacts with 
the ‘hot spots’ at residues 35, 55-57 and 124, while the 
C-terminal aromatic amino acid interacts with residues 
217/218. Consequently, peptide A may link two of the 
structural domains, and be directly involved in effec- 
ting the conformational change induced by the 
assembly-dependent GTP hydrolysis. In particular, the 
adoption of a lower energy state as a result of this 
hydrolysis may involve a change in the interaction bet- 
ween the multiple acidic residues of peptide A and the 
identified, and highly conserved, basic residues flank- 
ing the three ‘hot spots’ and at residue 215. This pro- 
posal specifically relates to the P-subunit: additional 
conformational changes presumably occur in the a- 
subunit induced by the ,&tubulin GTP hydrolysis. 
An important feature of this possibility is that it 
makes the precise predictions which are a pre-requisite 
for any informed site-directed mutagenesis. Although 
genetic insertions and deletions have been examined 
(for example, [ 15]), these have generally been made on 
the basis of available restriction sites rather than in 
respons to any specific structural model. The current 
difficulty in preparing significant amounts of 
monotypic tubulins, the various post-translational 
modifications, the mingling of isotypes in single 
microtubules (for example, [50,51]), and the 
cytoplasmic MAPS will all complicate any analysis of 
the functional role of the coordinated substitutions. 
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Possible methods, short of determining 
crystallographic structure, include combining 
directed mutagenesis with transplacement 
transfection. 
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